The efficacy of erythropoietin in human immunodeficiency virus—infected end-stage renal disease patients treated by maintenance hemodialysis

Shrivastava, Devesh Kumar; Rao, T. K. Sreepada; Sinert, Richard; Khurana, Esha; Lundin, A. Peter; Friedman, Eli A.

doi:10.1016/0272-6386(95)90573-1

Cited by 16 publications

(6 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Shrivastava et al [61]found that the mean baseline hematocrit of HIV-infected ESRD patients was 22% compared with 26% in HIV-negative, diabetic and non-diabetic ESRD patients. Similarly, Abbott et al [62]using data from Dialysis Morbidity and Mortality Wave 2 study found that mean hematocrit levels in patients with HIVAN (n = 37) were significantly lower compared with all other patients with ESRD starting dialysis (Hct 26.2 ± 6.5 vs. 30.5 ± 6.1, p < 0.05), respectively.…”

Section: Anemiamentioning

confidence: 99%

“…Prevalence of anemia is higher in HIV-infected patients with renal disease as anemia is the commonest hematological abnormality in HIV-infected patients and occurs in 3.2% of patients without clinical or immunologic AIDS but in 36.9% of patients with AIDS defining illness and 12.1% with immunologic AIDS [58][59][60]. Shrivastava et al [61] found that the mean baseline hematocrit of HIV-infected ESRD patients was 22% compared with 26% in HIV-negative, diabetic and non-diabetic ESRD patients. Similarly, Abbott et al [62] using data from Dialysis Morbidity and Mortality Wave 2 study found that mean hematocrit levels in patients with HIVAN (n = 37) were significantly lower compared with all other patients with ESRD starting dialysis (Hct 26.2 B 6.5 vs. 30.5 B 6.1, p !…”

Section: Anemiamentioning

confidence: 99%

See 1 more Smart Citation

Dialyzing a Patient with Human Immunodeficiency Virus Infection: What a Nephrologist Needs to Know

Mandayam

Ahuja

2004

Am J Nephrol

View full text Add to dashboard Cite

The percentage of dialysis centers that have reported dialyzing human immunodeficiency virus (HIV)-infected patients increased from 11% in 1985 to 37% in 2000. Being primary care physicians for the dialysis patients, nephrologists are frequently confronted with the management of HIV-infected dialysis patients especially in urban centers. The aims of the present review are to discuss issues that are unique to HIV infection and end-stage renal disease, and to provide dialysis caretakers with sufficient information to help them optimize care and improve outcomes of these patients. Issues related to the choice of renal replacement therapy, vascular access, management of anemia, vaccination, and antiretroviral therapies are discussed in detail.

show abstract

Section: Anemiamentioning

confidence: 99%

Section: Anemiamentioning

confidence: 99%

Dialyzing a Patient with Human Immunodeficiency Virus Infection: What a Nephrologist Needs to Know

Mandayam

Ahuja

2004

Am J Nephrol

View full text Add to dashboard Cite

show abstract

“…The response of anemia to EPO in HIV patients without renal disease is dependent on initial serum EPO levels. Similarly, in HIV-infected ESRD patients, those with lower serum levels respond better to exogenous EPO than those with higher baseline levels (102).…”

Section: Therapeutic Strategies In Esrd Patientsmentioning

confidence: 96%

Human Immunodeficiency Virus Infection in End‐Stage Renal Disease Patients

Rao

2003

Seminars in Dialysis

View full text Add to dashboard Cite

Human immunodeficiency virus (HIV) infection in patients with end-stage renal disease (ESRD) offers many diagnostic and therapeutic challenges to nephrologists. Renal failure may be a direct consequence of viral infection (HIV-associated nephropathy), or intrinsic renal diseases may occur in previously infected individuals. Patients receiving renal replacement therapy (RRT) may acquire HIV infection from blood transfusions, renal allografts, sexual contacts, or needle sharing by drug addicts. In the early 1980s, the overall prognosis of patients with the acquired immunodeficiency syndrome (AIDS) was very poor, and survival of those with ESRD was dismal. Consequently many even questioned the value of providing maintenance dialysis to patients with AIDS. With advances in diagnostic techniques in serologic and viral markers of disease, and deployment of highly effective antiretroviral agents, the prognosis of HIV-infected patients has dramatically improved. Over the past two decades, experiences in the management of HIV patients with ESRD is accumulating. Both peritoneal dialysis and hemodialysis are effective modes of therapy and many centers are now beginning to perform renal transplantation in HIV-infected patients. This article deals with various aspects of HIV infection in patients with ESRD.

show abstract

“…The response to recombinant erythropoietin (EPO) in HIV-infected patients with ESRD was similar to that in HIV-negative patients. 28 Measurements of iron indices are complicated in HIV-infected patients, especially as levels of ferritin are often elevated in patients with HIV infection.…”

Section: Renal Replacement Therapy In the Patient With Hiv Infectionmentioning

confidence: 99%

Human Immunodeficiency Virus Infection and the Kidney

Kopp¹,

Fabian²,

Naicker³

2010

Comprehensive Clinical Nephrology

View full text Add to dashboard Cite

The efficacy of erythropoietin in human immunodeficiency virus—infected end-stage renal disease patients treated by maintenance hemodialysis

Cited by 16 publications

References 19 publications

Dialyzing a Patient with Human Immunodeficiency Virus Infection: What a Nephrologist Needs to Know

Dialyzing a Patient with Human Immunodeficiency Virus Infection: What a Nephrologist Needs to Know

Human Immunodeficiency Virus Infection in End‐Stage Renal Disease Patients

Human Immunodeficiency Virus Infection and the Kidney

Contact Info

Product

Resources

About